Smoking cessation is cost effective from a long-term perspective, but less is known about its short-term cost-effectiveness. Short-term health benefits are clear for certain groups, such as ...

A daily pill that has been shown to double the chances of quitting smoking will launch in the UK next week, backed by £70 million ($89 million) in government funding for cessation programmes ...

A daily pill that helps people stop smoking is to be ... for varenicline's return to NHS use at a price agreed with the company. Champix and another oral smoking cessation therapy, GSK's Zyban ...

The adage “health is wealth” applies to the country and to individuals. While politicians debate conventional economic growth, it’s evident that the increasing impact of population ill health will be ...

(HealthDay News) — There is high-certainty evidence that incentives improve smoking cessation rates at long-term follow-up across populations, according to a review published online Jan. 13 in the ...

NHS Health Scotland said it wanted to "clarify" confusion around the harms and benefits of vaping devices ... we would encourage people providing smoking cessation serves to offer them as an ...

NHS England estimates that varenicline could help more than 85,000 people quit smoking each year, potentially preventing up to 9,500 smoking-related deaths annually. The benefits of quitting start ...

Varenicline will become another option for people using NHS stop smoking services in England. A branded version of the smoking cessation pill - known as Champix - was previously prescribed ...

We predict that a short-term perspective will continue to be the norm in the USA in calculating the benefits ... NHS, are able to focus on the longer term, leading to more and better smoking ...